Merck Overview

  • Status
  • Public

  • Employees
  • 61,508

Employees
  • Stock Symbol
  • MRK

Stock Symbol
  • Investments
  • 80

  • Share Price
  • $164.88

  • (As of Thursday Closing)

Merck General Information

Description

Merck KGaA operates in three main segments: life sciences, performance materials, and healthcare. The life sciences segment (46% of 2021 sales) provides laboratory consumables and instruments to researchers in academia and applied fields, including the biopharmaceutical industry. In the healthcare segment (36%), Merck develops, manufactures, and sells branded pharmaceuticals with significant therapeutic concentrations in oncology, multiple sclerosis, and fertility. In its electronics segment (18%), the company offers specialty materials to manufacture a variety of products, such as semiconductors, flat-screen televisions, automobiles, and cosmetics. In 1995, the E. Merck KG family publicly sold part of the company, resulting in the current 30% public ownership of the firm.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Specialty Chemicals
Stock Exchange
ETR
Primary Office
  • Frankfurter Strasse 250
  • 64293 Darmstadt
  • Germany
+49 06151 000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Merck Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$164.88 $166.89 $162.08 - $262.98 $71.7B 435M 343K $8.51

Merck Financials Summary

In Thousands,
USD
TTM 31-Mar-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 102,567,735 122,614,673 89,252,906 59,166,046
Revenue 23,524,902 23,275,913 19,987,233 18,081,272
EBITDA 7,023,555 7,096,156 5,603,812 4,577,410
Net Income 3,702,843 3,611,922 2,265,007 1,477,667
Total Assets 51,603,866 51,359,797 51,407,697 49,072,498
Total Debt 11,865,485 12,189,488 14,807,572 14,695,537
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Merck Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Merck‘s full profile, request access.

Request a free trial

Merck Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Merck KGaA operates in three main segments: life sciences, performance materials, and healthcare. The life sciences segm
Drug Discovery
Darmstadt, Germany
61,508 As of 2022
00.00
00000000 00.00

000000

uis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure do
000000000000000
Basel, Switzerland
000000 As of 0000
000000000000

00000

t amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliq
0000000000000
Basel, Switzerland
00000 As of 0000
00000
0.000 0000-00-00
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Merck Competitors (5)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Novartis Corporation Basel, Switzerland 000000 000000000000
00000 00000 Corporation Basel, Switzerland 00000 00000 00000000000 00000
00000 Corporation Leverkusen, Germany 000000 00.00 000000000 00.00
0000000 & 000000 0 Corporation Mumbai, India 0000
000000 Corporation New York, NY 00000 000000000-00
You’re viewing 5 of 5 competitors. Get the full list »

Merck Patents

Merck Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
DE-102020003383-A1 Method for storing and method for transmitting at least one piece of data, corresponding computer program products and devices Pending 04-Jun-2020 00000000000 0
EP-3915549-A1 Senescence inducers for use in the treatment and/or prevention of virus induced diseases Pending 26-May-2020 000000000 0
EP-3915549-A4 Senescence inducers for use in the treatment and/or prevention of virus induced diseases Pending 26-May-2020 000000000
DE-102020002607-A1 Pharmaceutical process Pending 30-Apr-2020 0000000000 0
EP-3892706-A3 Liquid-crystalline medium Pending 09-Apr-2020 C09K19/02 0
To view Merck’s complete patent history, request access »

Merck Executive Team (49)

Name Title Board Seat Contact Info
Marcus Kuhnert Ph.D Member of the Executive Board & Chief Financial Officer
Joern-Peter Halle Ph.D Chief Strategy Officer
Klaus-Reinhard Bischoff Director
Monika Kursawe Director
Evelyn Wiesmann Director Controlling Strategy & Transformations
You’re viewing 5 of 49 executive team members. Get the full list »

Merck Board Members (22)

Name Representing Role Since
000000000 0000 Merck Member of the Supervisory Board & Full-time Works Council Member 000 0000
0000 00000 Merck Member of the Supervisory Board 000 0000
000000000 00000 00.0 Merck Board Member 000 0000
000000 000000 Merck Member of the Supervisory Board 000 0000
0000000 00000 Merck Member of the Supervisory Board & Vice President Corporate Quality Assurance 000 0000
You’re viewing 5 of 22 board members. Get the full list »

Merck Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Merck Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Merck‘s full profile, request access.

Request a free trial

Merck Investments & Acquisitions (80)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 0000000 03-Mar-2022 0000000000 Drug Discovery
0000000 23-Feb-2022 0000000000 00000 Pharmaceuticals 00000 000
0000000 00000 30-Apr-2021 00000 0000 00.000 Other Agriculture
00000000 0000 01-Jan-2021 00000 0000 Drug Discovery
AmpTec 22-Dec-2020 Merger/Acquisition BPO/Outsource Services 000000 00
You’re viewing 5 of 80 investments and acquisitions. Get the full list »

Merck Subsidiaries (23)

Company Name Industry Location Founded
Exelead Pharmaceuticals Indianapolis, IN 2017
0000000000 Outcome Management (Healthcare) Kenya 0000
00000 0000000000 0 Accelerator/Incubator Darmstadt, Germany 0000
0000 00000000 Business/Productivity Software Darmstadt, Germany 0000
0000000000 0000000 Other Healthcare Technology Systems Meylan, France 0000
You’re viewing 5 of 23 subsidiaries. Get the full list »

Merck Exits (10)

Company Name Exit Date Exit Type Exit Size Status Buyers
00000000 000000000 01-Jan-2021 00000 00000 00 Completed
  • 2 buyers
00000000 000000000 01-Apr-2018 0000 00000 00.000 Completed
  • 2 buyers
00000 22-Nov-2017 00000 00000 00 00.000 Completed
  • 15 buyers
000000 07-Sep-2012 000000000 00000 00 00000 Completed
  • 00000
Enlight Biosciences 18-Jul-2008 Early Stage VC 0000 Completed
  • 4 buyers
You’re viewing 5 of 10 exits. Get the full list »